Open AccessRole of Serum Nitric Oxide in Prediction of Hepatocellular Carcinoma in Hepatitis C Patients Treated with Direct - Acting Antiviral Agents
Author(s) -
Basha OM,
Elsadek HM,
Mohamed Shokry,
Elsaid HH,
Farag Aa
Publication year - 2020
Publication title -
japanese journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2435-1210
DOI - 10.47829/jjgh.2020.5404
Subject(s) - hepatocellular carcinoma , nitric oxide , medicine , hepatitis c , hepatitis , gastroenterology , virology , pharmacology
AFP: Alpha feto-protein; AASLD: The American Association for the study of Liver Diseases; CPC: ChildPugh class; CHC: Chronic hepatitis C; CT = Computed tomography; DAC: Daclatasvir; DAAs: Direct-acting antiviral agents; FDA: Food and Drug Administration; HCV: Hepatitis C viral; HCC: Hepatocellular carcinoma; iNOS: Inducible Nitric Oxide Synthase; NO: Nitric Oxide; NS5A: Nonstructural protein 5A; NS5B: Nonstructural protein 5B; NS3: Nonstructural protein 3; sNO: Serum Nitric Oxide; RBV: Ribavirin; SOF: Sofosbuvir; SVR: Sustained viral response rate; BCLC: The Barcelona Clinic Liver Cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom